HCC Member

Inhye Ahn,MD

Dana-Farber Cancer Institute

Academic Titles
Assistant Professor, Medicine, Harvard Medical School
Research Program Affiliation
Member, Lymphoma and Myeloma
Member, Cancer Genetics and Epigenetics
Research Abstract

The overarching goals of my research are to uncover molecular mechanisms of treatment resistance and develop innovative therapies and individualized care for patients with chronic lymphocytic leukemia (CLL). To achieve these aims, I am leading clinical trials testing early intervention strategies in high-risk CLL and novel combination regimens in drug-resistant disease.